Logo Logo
Hilfe
Hilfe
Switch Language to English

Erlmeier, Franziska; Bruecher, Benedict; Stoehr, Christine; Herrmann, Edwin; Polifka, Iris; Agaimy, Abbas; Trojan, Lutz; Stroebel, Philipp; Becker, Frank; Wuelfing, Christian; Barth, Peter; Stoeckle, Michael; Staehler, Michael; Stief, Christian; Haferkamp, Axel; Hohenfellner, Markus; Macher-Goeppinger, Stephan; Wullich, Bernd; Noldus, Joachim; Brenner, Walburgis; Roos, Frederik C.; Walter, Bernhard; Otto, Wolfgang; Burger, Maximilian; Schrader, Andres Jan; Hartmann, Arndt; Mondorf, Yvonne; Ivanyi, Philipp; Mikuteit, Marie und Steffens, Sandra (2022): cMET: a prognostic marker in papillary renal cell carcinoma? In: Human Pathology, Bd. 121: S. 1-10

Volltext auf 'Open Access LMU' nicht verfügbar.

Abstract

The tyrosine-protein kinase c-Met plays a decisive role in numerous cellular processes, as a proto-oncogene that supports aggressive tumor behavior. It is still unknown whether c-Met could be relevant for prognosis of papillary RCC (pRCC). Specimen collection was a collaboration of the PAN-ZAR consortium. Patients' medical history and tumor specimens were collected from 197 and 110 patients with type 1 and 2 pRCC, respectively. Expression of cMET was determined by immunohistochemistry. In total, cMET staining was evaluable in of 97 of 197 type 1 and 63 of 110 type 2 pRCC cases. Five-year overall survival revealed no significant difference in dependence of cMET positivity (cMET(-) vs. cMET(+): pRCC type 1: 84.8% vs. 80.3%, respectively [p = 0.303, log-rank];type 2: 71.4% vs. 64.4%, respectively [p = 0.239, log-rank]). Interestingly, the subgroup analyses showed a significant difference for cMET expression in T stage and metastases of the pRCC type 2 (p = 0.014, p = 0.022, chi-square). The cMET-positive type 2 collective developed more metastases than the cMET-negative cohort (pRCC type 2 M+: cMET 2 [4.3%] vs. cMET(+): 12 [19%]). cMET expression did not qualify as a prognostic marker in pRCC for overall survival. (C) 2021 Elsevier Inc. All rights reserved.

Dokument bearbeiten Dokument bearbeiten